NCT00266123View on ClinicalTrials.gov

Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL

Enrollment

420

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

July 31, 2007

Conditions

Graft RejectionKidney FailureKidney Transplant

Interventions

DRUG

Sirolimus

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00266123 - Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter